Received Jul 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
administered priorix (in error) 1 year after receiving a dose of priorix; This non-serious case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a 5-year-old patient who received MMR (Priorix) for prophylaxis. Previously administered products included Priorix (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate age at vaccine administration (Verbatim: administered priorix (in error) 1 year after receiving a dose of priorix). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-JUL-2025 The nurse reported that she was seeking some literature to provide to her corporate team about the potential side effects to a patient 5 years old who was administered Priorix vaccine in error 1 year after receiving a dose of Priorix, which led to inappropriate age at vaccine administration.